Primitive cardiac sarcomas: about 2 cases

The cardiac sarcomas, although very rare, represent the quasi-totality of the primitive sly tumors of the heart. It is about a retrospective study of two cases of cardiac sarcomas operated in Sahloul university hospital of Sousse. Cases it is about a woman and a man: The respective ages were 22 and 45 years. The clinical pattern of the patients was polymorphic and the diagnosis put by cardiac echography. Both patients had a surgical resection and a chemotherapy. Both patients died in 13 and 18 months after the diagnosis. Because of the extreme rarity of the cardiac sarcomas, there is no precise therapeutic strategy. The only consensus concerns the surgery as soon as the diagnosis of cardiac tumor is put. The prognosis of these tumors is extremely redoubtable with a survival which does not exceed 2 years after the beginning of the symptomatology

Congenital Abdominal Infra Renal Aortic Anenrysm in infants

Abdominal aortic aneurysm is extremely rare in infant and is generally due to infection, umbilical artery catheterization. vasculitis, connective tissue diseases and tuberous sclerosis. At the absence of these evident causes, it is a congenital primary aortic aneurysm which is exceedingly rare and only a few cases have of which have been reported. Here we report two cases of aortic wall reconstruction done by a Goretex patch. The immediate result is excellent with a reestablishment of the femoral pulse and an excellent Doppler control The problem which we may face in the future is probably the aortic out come with this Goretex patch a continaons follow up of these patients is necessary

[Chronic aortic regurgitation with left ventricular dysfonction]

We studied fifty one patients [40 men and 11 women] undergoing valve replacement from 1990 to 2002 for aortic regurgitation and had left ventricular dysfunction. 45% patients were in class III or IV of New York Heart Association [NYHA]. All patients were investigated by echocardiography [left ventricular ejection fraction [LVEF] <50%] - Peroperative mortality was 5.8% due to myocardial failure. 81.4% of survivors were followed during a mean period of 24 months [rangies from 3 to 67 months] after valve replacement